Lipopolysaccharide-and superantigen-modulated superoxide production and monocyte hyporesponsiveness to activating stimuli in Sepsis

Dhanonjoy C. Saha, Mark E. Astiz, Lesley Jane Eales-Reynolds, Eric C. Rackow

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effects of acute and prior exposure to lipopolysaccharide (LPS) and staphylococcal enterotoxin B (SEB) on superoxide release by monocytes were examined in control subjects and in patients with sepsis and septic shock during the acute stage and recovery. High doses of LPS, PMA (phorbol 12-myristate 13-acetate), and SEB stimulated monocyte superoxide release in control subjects (P <0.05). Pretreatment of normal monocytes with these doses of LPS, PMA, and SEB induced significant hyporesponsiveness to subsequent challenge (P <0.01), and evidence of cross-tolerance was observed. Monocytes isolated from patients with sepsis and septic shock demonstrated high spontaneous superoxide release compared with those of control subjects (P <0.05). Stimulation of patient monocytes with LPS or SEB resulted in less superoxide production than that spontaneously released by controls (P <0.01). In patients recovering from their initial infection, spontaneous superoxide release was less than that released during acute stage. In addition, the superoxide release in response to the same stimuli was significantly increased when compared with release during the acute stage (P <0.05). These data demonstrate that both LPS and SEB induce hyporesponsiveness to LPS-or SEB-stimulated superoxide release. A similar pattern of hyporesponsiveness was observed during sepsis that may represent a mechanism for modulating the inflammatory response during severe infections.

Original languageEnglish (US)
Pages (from-to)43-48
Number of pages6
JournalShock
Volume38
Issue number1
DOIs
StatePublished - Jul 2012
Externally publishedYes

Fingerprint

Superantigens
Superoxides
Lipopolysaccharides
Monocytes
Sepsis
Septic Shock
Acetates
Infection
staphylococcal enterotoxin B

Keywords

  • lipopolysaccharide
  • monocytes
  • sepsis
  • staphylococcal enterotoxin B
  • Superoxide

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine

Cite this

Lipopolysaccharide-and superantigen-modulated superoxide production and monocyte hyporesponsiveness to activating stimuli in Sepsis. / Saha, Dhanonjoy C.; Astiz, Mark E.; Eales-Reynolds, Lesley Jane; Rackow, Eric C.

In: Shock, Vol. 38, No. 1, 07.2012, p. 43-48.

Research output: Contribution to journalArticle

Saha, Dhanonjoy C. ; Astiz, Mark E. ; Eales-Reynolds, Lesley Jane ; Rackow, Eric C. / Lipopolysaccharide-and superantigen-modulated superoxide production and monocyte hyporesponsiveness to activating stimuli in Sepsis. In: Shock. 2012 ; Vol. 38, No. 1. pp. 43-48.
@article{88587644bafa496dbb0a6bdb63ecfa82,
title = "Lipopolysaccharide-and superantigen-modulated superoxide production and monocyte hyporesponsiveness to activating stimuli in Sepsis",
abstract = "The effects of acute and prior exposure to lipopolysaccharide (LPS) and staphylococcal enterotoxin B (SEB) on superoxide release by monocytes were examined in control subjects and in patients with sepsis and septic shock during the acute stage and recovery. High doses of LPS, PMA (phorbol 12-myristate 13-acetate), and SEB stimulated monocyte superoxide release in control subjects (P <0.05). Pretreatment of normal monocytes with these doses of LPS, PMA, and SEB induced significant hyporesponsiveness to subsequent challenge (P <0.01), and evidence of cross-tolerance was observed. Monocytes isolated from patients with sepsis and septic shock demonstrated high spontaneous superoxide release compared with those of control subjects (P <0.05). Stimulation of patient monocytes with LPS or SEB resulted in less superoxide production than that spontaneously released by controls (P <0.01). In patients recovering from their initial infection, spontaneous superoxide release was less than that released during acute stage. In addition, the superoxide release in response to the same stimuli was significantly increased when compared with release during the acute stage (P <0.05). These data demonstrate that both LPS and SEB induce hyporesponsiveness to LPS-or SEB-stimulated superoxide release. A similar pattern of hyporesponsiveness was observed during sepsis that may represent a mechanism for modulating the inflammatory response during severe infections.",
keywords = "lipopolysaccharide, monocytes, sepsis, staphylococcal enterotoxin B, Superoxide",
author = "Saha, {Dhanonjoy C.} and Astiz, {Mark E.} and Eales-Reynolds, {Lesley Jane} and Rackow, {Eric C.}",
year = "2012",
month = "7",
doi = "10.1097/SHK.0b013e318257ed62",
language = "English (US)",
volume = "38",
pages = "43--48",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Lipopolysaccharide-and superantigen-modulated superoxide production and monocyte hyporesponsiveness to activating stimuli in Sepsis

AU - Saha, Dhanonjoy C.

AU - Astiz, Mark E.

AU - Eales-Reynolds, Lesley Jane

AU - Rackow, Eric C.

PY - 2012/7

Y1 - 2012/7

N2 - The effects of acute and prior exposure to lipopolysaccharide (LPS) and staphylococcal enterotoxin B (SEB) on superoxide release by monocytes were examined in control subjects and in patients with sepsis and septic shock during the acute stage and recovery. High doses of LPS, PMA (phorbol 12-myristate 13-acetate), and SEB stimulated monocyte superoxide release in control subjects (P <0.05). Pretreatment of normal monocytes with these doses of LPS, PMA, and SEB induced significant hyporesponsiveness to subsequent challenge (P <0.01), and evidence of cross-tolerance was observed. Monocytes isolated from patients with sepsis and septic shock demonstrated high spontaneous superoxide release compared with those of control subjects (P <0.05). Stimulation of patient monocytes with LPS or SEB resulted in less superoxide production than that spontaneously released by controls (P <0.01). In patients recovering from their initial infection, spontaneous superoxide release was less than that released during acute stage. In addition, the superoxide release in response to the same stimuli was significantly increased when compared with release during the acute stage (P <0.05). These data demonstrate that both LPS and SEB induce hyporesponsiveness to LPS-or SEB-stimulated superoxide release. A similar pattern of hyporesponsiveness was observed during sepsis that may represent a mechanism for modulating the inflammatory response during severe infections.

AB - The effects of acute and prior exposure to lipopolysaccharide (LPS) and staphylococcal enterotoxin B (SEB) on superoxide release by monocytes were examined in control subjects and in patients with sepsis and septic shock during the acute stage and recovery. High doses of LPS, PMA (phorbol 12-myristate 13-acetate), and SEB stimulated monocyte superoxide release in control subjects (P <0.05). Pretreatment of normal monocytes with these doses of LPS, PMA, and SEB induced significant hyporesponsiveness to subsequent challenge (P <0.01), and evidence of cross-tolerance was observed. Monocytes isolated from patients with sepsis and septic shock demonstrated high spontaneous superoxide release compared with those of control subjects (P <0.05). Stimulation of patient monocytes with LPS or SEB resulted in less superoxide production than that spontaneously released by controls (P <0.01). In patients recovering from their initial infection, spontaneous superoxide release was less than that released during acute stage. In addition, the superoxide release in response to the same stimuli was significantly increased when compared with release during the acute stage (P <0.05). These data demonstrate that both LPS and SEB induce hyporesponsiveness to LPS-or SEB-stimulated superoxide release. A similar pattern of hyporesponsiveness was observed during sepsis that may represent a mechanism for modulating the inflammatory response during severe infections.

KW - lipopolysaccharide

KW - monocytes

KW - sepsis

KW - staphylococcal enterotoxin B

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=84862757790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862757790&partnerID=8YFLogxK

U2 - 10.1097/SHK.0b013e318257ed62

DO - 10.1097/SHK.0b013e318257ed62

M3 - Article

C2 - 22575995

AN - SCOPUS:84862757790

VL - 38

SP - 43

EP - 48

JO - Shock

JF - Shock

SN - 1073-2322

IS - 1

ER -